Blacktrace
Sector
Scientific Technology
Deal Type
Growth Capital
Initial Investment
April 2016
Transaction size
£4.25m
Location
Cambridge
Maven Office
Edinburgh
About Blacktrace
Blacktrace designs, develops and manufactures cutting-edge technologies and products for many applications in chemistry, microfluidics, biology, and nanomaterial sciences. The business has built a reputation for world-class innovation and continuous development of new products and technologies, with its portfolio of products now marketed and sold globally.
Established in 2001, the Blacktrace has grown year on year and now employs a large team of world-class scientists and engineers at its state-of-the-art testing and manufacturing facility near Cambridge. Its customers include all the top 20 pharmaceutical companies, a wide range of major academic institutes, biotechs, start-ups, petrochemical companies, and food manufacturers.
The Blacktrace team have been working hard over the last few years to develop a diverse range of revolutionary products. To support the launch of these new products we embarked on a process to identify a funding partner and we were delighted to be introduced to the Maven team who immediately understood our business and products, shared our vision and were able to provide the funding package we had been seeking. We have developed a strong working relationship with Maven and we look forward to working with them as we scale the business and roll out our exciting new range of products.
Mark Gilligan, Chairman and CEO at Blacktrace
Interested in growth capital for your business? Then get in touch with our investment team
Contact us